A revolutionary study performed by UNIST's Department of Biological Sciences' Professor Sebyung Kang and Professor Sung Ho Park has shown a significant advance in cancer therapy. The study team has successfully generated novel "NK cell-engaging nanodrones" capable of specifically targeting
A new study published in Science Advances explains how an enzyme called SMYD3 may play a role in the advancement of prostate cancer to a more hazardous and aggressive stage.
For far too long, cancer treatment has been a double-edged sword, with treatments designed to target cancer cells sometimes harming healthy cells as well.
For far too long, cancer treatment has been a two-edged sword, with therapies designed to target cancer cells frequently wreaking damage on good cells as well.
In theory, a team from the University of Massachusetts Amherst proved that a protein antigen from a childhood vaccine may be administered into the cells of a malignant tumour to reorient the body's immune system against the cancer, effectively stopping it and preventing its recurrence.
According to a recent study, a new therapy regimen safely reduced the growth of pancreatic cancer in mice by stopping the cancer cells from scavenging for fuel.
Even for killer T cells, which are specialised immune cells, searching for and eliminating cancer cells around the clock can be challenging. Scientists can produce stronger cancer-killing cells if they understand why killer T cells become exhausted.
Two new genes have been discovered by Queen Mary University of London researchers that render people with head and neck cancer resistant to chemotherapy. Cancer cells that were previously resistant to chemotherapy can now respond to it by silencing one of these genes.
Researchers from Queen Mary University of London have identified two new genes that make patients with head and neck cancer resistant to chemotherapy. By suppressing one of these genes, cancer cells that were previously resistant to chemotherapy can now respond to it.